• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Exploring Therapies for Platinum Sensitive & Platinum-Resistant Ovarian Cancer

Opinion
Video

A medical expert discusses efficacy of approaches such as carboplatin doublets, checkpoint inhibitors, and PARP inhibitors for patients with platinum sensitive and platinum-resistant ovarian cancer.

Related Videos
4 Experts are featured in this series
4 Experts are featured in this series
2 experts in this video
2 experts in this video
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
5 experts in this video
© 2025 MJH Life Sciences
AJMC®
All rights reserved.